What's New

Follow Us

End the Epidemic of Childhood Obesity...One Family at a Time

Marti Jordan-Welch, PhD, FNP-BC, RN, and Bonnie Lee Harbaugh, PhD, RN

Overview:

The number of overweight American children keeps growing at a rate that's hard to swallow. And so does the number of American children at risk for becoming overweight. Unless we stop the spread of this problem now, the long-term debilitating effects on today's children-and ultimately, on their children-will exhaust our health care resources.

Objectives:

1. Describe the obesity epidemic and its consequences. 2. Describe the guidelines of the American Medical Association’s Expert Committee on the Assessment, Prevention, and Treatment of Child and Adolescent Overweight and Obesity. 3. Discuss the role of the nurse in preventing and managing childhood obesity. 4. Explain the staged approach to treatment of childhood obesity.

Author:

Marti Jordan-Welch, PhD, FNP-BC, RN, is an Assistant Professor, and Bonnie Lee Harbaugh, PhD, RN, is an Associate Professor at the University of Southern Mississippi School of Nursing in Hattiesburg.
Marti Jordan-Welch holds stock in Pfizer.

Bonnie Lee Harbaugh and the planners of this CNE activity have disclosed no relevant financial relationships with any commercial companies pertaining to this activity.

The American Nurses Association Center for Continuing Education and Professional Development is accredited as a provider of continuing
nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

ANCC Provider Number 0023.

ANA is approved by the California Board of Registered Nursing, Provider Number CEP6178.

ANA's accredited provider
status refers only to continuing nursing education activities and does
not imply that there is real or implied endorsement of any product,
service, or company referred to in CNE activities nor of any company
subsidizing costs related to these activities.

ANA's CNE activities do not include any unannounced information about
off-label use of a product for a purpose other than that for which it
was approved by the Food and Drug Administration (FDA).